Re: quick CELG Analysis
Geno587 - Nov 24, 2008 (3 posts)
I have..but google does nothing. Google = spam
Geno587 - Nov 24, 2008 (3 posts)
I have..but google does nothing. Google = spam
Celgene Corporation - SWOT Analysis - companiesandmarkets.com adds ... | |
PR-Inside.com (Pressemitteilung) - 3 hours ago |
Options Update: Merck volatility elevated into lower 2009 outlook; ... | |
BloggingStocks - 5 hours ago |
CELG: To Present At NASDAQ OMX Investor Conference @ 03:00 ET ... | |
Trading Markets (press release) - 6 hours ago |
Celgene Corporation and Acceleron Pharma to Present ACE-011 Data ... | |
Business Wire (press release) - Dec 3, 2008 |
Option Skews - National City Corp, DryShips Inc, Marvell Technology... | |
Schaeffers Research - Dec 2, 2008 |
Celgene Corporation's Celgene Cellular Therapeutics Receives FDA ... | |
Reuters Key Development - Nov 10, 2008 |
Jan 29, 2009 | Q4 2008 Earnings Release - 8:30AM EST Add to calendar |
Dec 4, 2008 | Nasdaq International OMX 22nd Investor Conference Webcast |
Nov 19, 2008 | Lazard Capital Markets Healthcare Conference Webcast |
Nov 12, 2008 | Credit Suisse Group Healthcare Conference Webcast |
Nov 11, 2008 | Rodman & Renshaw Annual Global Investment Conference Webcast |
Nov 3, 2008 | Oppenheimer & Co. Annual Healthcare Conference Webcast |
Oct 23, 2008 | Q3 2008 Earnings Release |
Oct 23, 2008 | Q3 2008 Earnings Conference Call Webcast |
Oct 7, 2008 | JMP Securities LLC Healthcare Focus Conference Webcast |
Sep 23, 2008 | UBS Global Life Sciences Conference Webcast |
More events from AOL Finance »
|
Sol J. Barer Ph.D. > | Chairman of the Board, Chief Executive Officer |
Robert J. Hugin > | President, Chief Operating Officer, Director |
David W. Gryska > | Chief Financial Officer, Senior Vice President |
Aart Brouwer > | President, International |
Graham Burton > | Senior Vice President - Regulatory Affairs, Pharmacovigilance and Corporate Compliance |
Michael D. Casey > | Lead Independent Director |
Arthur Hull Hayes Jr.M.D. > | Director |
Gilla Kaplan Ph.D. > | Director |
Walter L. Robb Ph.D. > | Director |
Rodman L. Drake > | Director |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Volume delayed by 15 min. |
Income Statement |
Quarterly (Sep '08) |
Annual (2007) |
Annual (2006) |
|
Total Revenue | 592.47 | 1,405.82 | 898.87 | |
Gross Profit | 521.93 | 1,275.58 | 772.98 | |
Operating Income | 159.58 | 425.12 | 174.69 | |
Net Income | 136.81 | 226.43 | 68.98 | |
Balance Sheet | ||||
Total Current Assets | 3,024.21 | 3,084.42 | 2,311.00 | |
Total Assets | 4,357.42 | 3,611.28 | 2,735.79 | |
Total Current Liabilities | 449.01 | 432.93 | 239.70 | |
Total Liabilities | 769.06 | 767.34 | 759.61 | |
Total Equity | 3,588.36 | 2,843.94 | 1,976.18 | |
Cash Flow | ||||
Net Income/Starting Line | 136.81 | 226.43 | 68.98 | |
Cash from Operating Activities | 217.74 | 477.50 | 83.56 | |
Cash from Investing Activities | -59.61 | -990.19 | 6.78 | |
Cash from Financing Activities | 70.24 | 287.69 | 1,221.25 | |
Net Change in Cash | 168.45 | -221.14 | 1,316.10 |
Quarterly (Sep '08) | Annual (2007) | Annual (TTM) | ||
Net Profit Margin | 23.09% | 16.11% | -64.13% | |
Operating Margin | 26.93% | 30.24% | -58.41% | |
EBITD Margin | - | 32.48% | -52.90% | |
Return on Average Assets | 12.92% | 7.14% | -33.87% | |
Return on Average Equity | 15.64% | 9.40% | -43.15% | |
Employees | 1,685 | - | - | |
More ratios from Thomson Reuters » |
86 Morris Avenue
Summit, NJ 07901 United States - Map +1-908-6739000 (Phone) +1-732-2714184 (Fax) |
Company website: http://www.celgene.com/ News Releases, Investor Relations, Financial Information, Corporate History/Profile, Executives, Products/Services, Employment Opportunities |